about
Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosusCell-bound complement activation products in SLE.Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE.Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLEDiffering contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanerceptCell-bound complement activation products associate with lupus severity in SLE
P50
description
researcher (ORCID 0000-0002-3799-4438)
@en
wetenschapper
@nl
name
Thierry Dervieux
@en
Thierry Dervieux
@nl
type
label
Thierry Dervieux
@en
Thierry Dervieux
@nl
prefLabel
Thierry Dervieux
@en
Thierry Dervieux
@nl
P31
P496
0000-0002-3799-4438